<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Aging</journal-id>
<journal-title-group>
<journal-title>Frontiers in Aging</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Aging</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2673-6217</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1754569</article-id>
<article-id pub-id-type="doi">10.3389/fragi.2026.1754569</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Ectoine attenuates H<sub>2</sub>O<sub>2</sub>-Induced cellular senescence in human keratinocytes and endothelial cells by modulating the p53/p21 and p16 pathways</article-title>
<alt-title alt-title-type="left-running-head">Li et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fragi.2026.1754569">10.3389/fragi.2026.1754569</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Li</surname>
<given-names>Meini</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3293701"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal Analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing - original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhang</surname>
<given-names>Jingyue</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal Analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Wenke</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3061373"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miao</surname>
<given-names>Zengqiang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing - original draft</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pai</surname>
<given-names>Yanran</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yi</surname>
<given-names>Yi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shuang</surname>
<given-names>Jie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Gao</surname>
<given-names>Xiang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal Analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Yongzhen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3385255"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal Analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Department of Basic Medical Sciences, Qinghai University Medical College</institution>, <city>Xining</city>, <state>Qinghai</state>, <country country="CN">China</country>
</aff>
<aff id="aff2">
<label>2</label>
<institution>Department of Clinical Laboratory, Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People&#x2019;s Hospital</institution>, <city>Guigang</city>, <state>Guangxi</state>, <country country="CN">China</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Yongzhen Li, <email xlink:href="mailto:liyongzhen885@qhu.edu.cn">liyongzhen885@qhu.edu.cn</email>; Xiang Gao, <email xlink:href="mailto:gaoxiang@qhu.edu.cn">gaoxiang@qhu.edu.cn</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>&#x2020;</label>
<p>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-26">
<day>26</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>7</volume>
<elocation-id>1754569</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>09</day>
<month>02</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>02</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Li, Zhang, Yang, Miao, Pai, Yi, Shuang, Gao and Li.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Li, Zhang, Yang, Miao, Pai, Yi, Shuang, Gao and Li</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-26">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Ectoine ((S)-2-methyl-1,4,5,6-tetrahydropyrimidine-4-carboxylic acid) is a major compatible solute found in halophilic microorganisms from salt lakes. The anti-cellular senescence effect and skin safety of Ectoine on H<sub>2</sub>O<sub>2</sub>-induced oxidative stress senescence in HaCaT cells and EA. hy926 endothelial cells were evaluated through a series of <italic>in vitro</italic> assays.</p>
</sec>
<sec>
<title>Methods</title>
<p>An oxidative stress senescence model was established using H<sub>2</sub>O<sub>2</sub> in HaCaT and EA. hy926 cells pretreated with various concentrations of Ectoine. Cell viability was assessed using the CCK-8 assay, proliferative capacity was evaluated with the EdU assay, and senescence status was determined by SA-&#x3b2;-gal staining. Intracellular ROS levels were measured using a DCFH probe, and cell death was analysed by flow cytometry. The expression of senescence-related markers was evaluated at the transcriptional and protein levels: The mRNA levels of <italic>TP53</italic>, <italic>CDKN1A</italic> (encoding p21), <italic>CDKN2A</italic> (encoding p16), <italic>MMP2</italic>, and <italic>MMP9</italic> were measured by qRT&#x2012;PCR, while their corresponding protein products (p53, p21, and p16) were analysed by Western blotting. Lamin B1 expression was examined by immunofluorescence.</p>
</sec>
<sec>
<title>Results</title>
<p>Exposure to H<sub>2</sub>O<sub>2</sub> successfully induced cellular senescence, as evidenced by increased SA-&#x3b2;-gal activity, elevated ROS levels, and upregulated expression of senescence-associated markers (<italic>TP53, CDKN1A</italic>, <italic>CDKN2A</italic>, <italic>MMP2</italic>, and <italic>MMP9</italic>), along with decreased Lamin B1 expression. Ectoine pretreatment significantly attenuated these senescence phenotypes in a concentration-dependent manner, with 0.50&#xa0;&#x3bc;mol/L identified as the most effective concentration. At this dosage, Ectoine enhanced cell viability, reduced ROS accumulation, and suppressed cell death without causing cytotoxicity. Mechanistically, Ectoine downregulated the expression of the p53/p21 and p16 pathway components, thereby inhibiting cell cycle arrest.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Ectoine exerts potent anti-senescence effects in H<sub>2</sub>O<sub>2</sub>-induced models of skin-related cell senescence, primarily by modulating the p53/p21 and p16 signalling pathways and reducing oxidative damage. These findings may support further exploration of its potential application in anti-cellular senescence research.</p>
</sec>
</abstract>
<kwd-group>
<kwd>cellular senescence</kwd>
<kwd>Ectoine</kwd>
<kwd>HaCaT</kwd>
<kwd>oxidative stress</kwd>
<kwd>p53/p21</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This research was funded by the National Natural Science Foundation of China (No. 82560395), the National Natural Science Foundation of China (No. 21967018), Qinghai Province&#x2019;s 2022 &#x2018;Kunlun Elite&#xb7;High-End Innovation and Entrepreneurship Talent&#x2019; Top Talent Cultivation Programme, and the Natural Science Foundation of Guangxi (No. 2024GXNSFBA010056).</funding-statement>
</funding-group>
<counts>
<fig-count count="6"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="23"/>
<page-count count="11"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Cellular Senescence</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<label>1</label>
<title>Introduction</title>
<p>As people age, concern regarding skin condition increases, and skin wrinkles represent a typical ageing-related phenomenon. The ageing process of skin can be divided into intrinsic ageing and extrinsic ageing (<xref ref-type="bibr" rid="B16">Krutmann et al., 2021</xref>). Cellular senescence, a key contributor to ageing, can be triggered by various stressors, including reactive oxygen species (ROS) and environmental factors (<xref ref-type="bibr" rid="B21">Tubbs and Nussenzweig, 2017</xref>; <xref ref-type="bibr" rid="B14">Jackson and Bartek, 2009</xref>). Studies on many senescence biomarkers and related mechanistic pathways associated with skin failure have been conducted in animal and <italic>in vitro</italic> models. Skin-related cells (e.g., keratinocytes) exposed to UVB light exhibit DNA damage and cell cycle arrest and express senescence biomarkers such as increased senescence-associated &#x3b2;-galactosidase (SA-&#x3b2;-Gal) activity; <italic>TP53</italic>, <italic>CDKN1A</italic>, and <italic>CDKN2A</italic> activation; and downregulation of Lamin B1 expression (<xref ref-type="bibr" rid="B8">Csekes and Ra&#x10d;kov&#xe1;, 2021</xref>). The expression of p16 is rapidly upregulated following ultraviolet irradiation and in response to H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in a p38 stress-activated protein kinase-dependent manner (<xref ref-type="bibr" rid="B16">Krutmann et al., 2021</xref>). Several natural plant extracts, such as rhizocortin, gallic acid, and fexofenone, have been reported to have inhibitory effects on &#x3b2;-galactosidase activity, ROS levels, and p53 and p16 expression in human skin keratinocytes, thereby slowing ageing (<xref ref-type="bibr" rid="B17">Nistic&#xf2; et al., 2015</xref>; <xref ref-type="bibr" rid="B20">Shin et al., 2014</xref>; <xref ref-type="bibr" rid="B19">Seo and Jeong, 2015</xref>).</p>
<p>Ectoine, a compatible solute, was first identified and structurally characterized in the saline photosynthetic violet bacterium <italic>Salmonella</italic> salina (<italic>Ectothiorhodospira halochloris</italic>) in 1985 (<xref ref-type="bibr" rid="B10">Galinski et al., 1985</xref>), and Rakesh et al. (<xref ref-type="bibr" rid="B11">Harishchandra et al., 2010</xref>) reported that the preferential exclusion model for the protection of macromolecules is based on the following mechanism: Ectoine protects affected cell membranes from desiccation-induced responses and subsequent inflammatory reactions by forming a water shell (Ectoine-water complexes) around the protein through a &#x201c;preferential hydration&#x201d; effect. In addition, increased hydration of cell membranes improves the fluidity and functionality of the lipid layer, and Ectoine promotes the formation of water molecule clusters; therefore, the preferential exclusion model attributes the stabilizing effect of Ectoine to changes in the surrounding water structure, which not only maintains the intra- and extracellular osmotic pressure but also increases the water content. Ectoine not only maintains intra- and extracellular osmotic pressure, increasing resistance to extreme conditions and reducing transdermal water loss, but also has a cell-stabilizing effect by protecting whole cells and biomolecules (extracellular polysaccharides, enzymes, DNA, antibodies, etc.) under harsh environmental conditions (e.g., high temperature, low temperature, or dryness) (<xref ref-type="bibr" rid="B12">Held and Sadowski, 2016</xref>). It also protects cells from oxidative damage (<xref ref-type="bibr" rid="B13">Hseu et al., 2020</xref>) and has good stress protection, functional maintenance and anti-inflammatory properties (<xref ref-type="bibr" rid="B9">Czech et al., 2018</xref>), and recent studies have reported that Ectoine can be used as an additive in skincare products such as skin whitening, moisturizing, antiaging, and UV protection products (<xref ref-type="bibr" rid="B13">Hseu et al., 2020</xref>; <xref ref-type="bibr" rid="B2">Bownik and St&#x119;pniewska, 2015</xref>; <xref ref-type="bibr" rid="B3">Bownik and St&#x119;pniewska, 2016</xref>); therefore, Ectoine has very good potential for use in biomedical development and other fields.</p>
<p>HaCaT cells are immortalized cell lines derived from the spontaneous transformation of human skin keratinocytes, and their physiological properties are very similar to those of skin keratinocytes, which have long been regarded as reliable and stable cell lines in the field of skin research (<xref ref-type="bibr" rid="B23">Zhang et al., 2023</xref>). EA. hy926 endothelial cells, as a fusion line of human umbilical vein endothelial cells (HUVECs), are more likely to be HUVECs and are easier to culture <italic>in vitro</italic>; therefore, these cells have been widely adopted by researchers in recent years (<xref ref-type="bibr" rid="B6">Chavez et al., 2024</xref>).</p>
<p>In this study, we investigated the potential anti-senescence efficacy of Ectoine on skin-related cells using human immortalized keratinocytes (HaCaT cells) and human umbilical vein endothelial cells (EA.hy926) to establish an oxidative stress-induced cellular senescence model. We explored the effects of Ectoine on oxidative stress-induced senescent skin-related cells related to the Lamin B1, ROS, p53/p21 and p16 pathways.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2-1">
<label>2.1</label>
<title>Materials and cell lines</title>
<p>Ectoine was obtained from Damas-beta (Cat No. 011009959 91759B). HaCaT cells were purchased from Shanghai Fuheng Biotechnology Co., Ltd. (Cat No. FH0186). EA. hy926 cells were kindly provided by the Antitumour Group of Chinese and Tibetan Medicines (CTmat, Qinghai University, China).</p>
</sec>
<sec id="s2-2">
<label>2.2</label>
<title>Cell culture and general experimental procedures</title>
<sec id="s2-2-1">
<label>2.2.1</label>
<title>Cell culture and treatment protocol</title>
<p>Cells were seeded at a density of 2 &#xd7; 10<sup>5</sup> cells/mL in appropriate culture plates. In 96-well plates, 100&#xa0;&#x3bc;L of cell suspension was added to each well, with peripheral wells filled with 100&#xa0;&#x3bc;L of PBS to minimize edge effects. To 6-well plates, 1&#xa0;mL of cell suspension was added per well. After approximately 60% confluence was reached, the cells were grouped according to the experimental design and treated as specified in the subsequent sections. All the cells were maintained at 37&#xa0;&#xb0;C in a 5% CO<sub>2</sub> incubator.</p>
</sec>
<sec id="s2-2-2">
<label>2.2.2</label>
<title>Cytotoxicity assessment</title>
<p>Cell viability was determined using the CCK-8 assay. Following treatment with Ectoine (0.25&#x2013;2&#xa0;&#x3bc;mol/L) or H<sub>2</sub>O<sub>2</sub> (100&#x2013;400&#xa0;&#x3bc;mol/L) as described in the respective experimental sections, 10&#xa0;&#x3bc;L of CCK-8 solution was added to each well and incubated for 0.5&#xa0;h. Absorbance was measured at 450&#xa0;nm using a microplate reader.</p>
</sec>
</sec>
<sec id="s2-3">
<label>2.3</label>
<title>EdU proliferation assay</title>
<p>Cell proliferation was assessed using an EdU cell proliferation kit according to the manufacturer&#x2019;s instructions. Briefly, cells were treated as specified, incubated with EdU solution for 2 h, fixed, and stained with Apollo<sup>&#xae;</sup> dye. The nuclei were counterstained with Hoechst 33342. Images were acquired using a fluorescence microscope, and proliferation rates were calculated as the ratio of EdU-positive cells to total cells using ImageJ software.</p>
</sec>
<sec id="s2-4">
<label>2.4</label>
<title>Senescence-associated &#x3b2;-galactosidase staining</title>
<p>Cellular senescence was detected using an SA-&#x3b2;-gal staining kit according to the manufacturer&#x2019;s protocol. After treatment, the cells were fixed with fixative solution for 15&#xa0;min at room temperature and incubated with staining solution overnight at 37&#xa0;&#xb0;C without CO<sub>2</sub>. Senescent cells were identified by blue staining under a light microscope.</p>
</sec>
<sec id="s2-5">
<label>2.5</label>
<title>Intracellular ROS measurement</title>
<p>Intracellular ROS levels were measured using a DCFH-DA fluorescent probe. Following treatment, the cells were incubated with 10&#xa0;&#x3bc;mol/L DCFH-DA at 37&#xa0;&#xb0;C for 20&#xa0;min and then were washed with PBS, after which the fluorescence intensity was immediately measured using a fluorescence microscope. Quantitative analysis was performed using ImageJ software.</p>
</sec>
<sec id="s2-6">
<label>2.6</label>
<title>Quantitative real-time PCR</title>
<p>Total RNA was extracted using TRIzol reagent, and cDNA was synthesized using the PrimeScript RT reagent kit. Quantitative PCR was performed using SYBR Green Premix on a real-time PCR system. Gene expression levels were normalized to those of &#x3b2;-actin and calculated using the 2<sup>(-&#x394;&#x394;Ct)</sup> method. The primer sequences used in this study are listed in <xref ref-type="sec" rid="s12">Supplementary Table S1</xref>.</p>
</sec>
<sec id="s2-7">
<label>2.7</label>
<title>Western blot analysis</title>
<p>Total protein was extracted using RIPA lysis buffer, and the protein concentration was determined using a BCA assay. The proteins were separated by SDS&#x2012;PAGE and transferred to PVDF membranes. After blocking with 5% nonfat milk, the membranes were incubated with primary antibodies against p53, p21, p16 and &#x3b2;-actin overnight at 4&#xa0;&#xb0;C, followed by incubation with HRP-conjugated secondary antibodies. The protein bands were visualized using the ECL substrate and quantified using ImageJ software.</p>
</sec>
<sec id="s2-8">
<label>2.8</label>
<title>Immunofluorescence staining</title>
<p>Cells grown on coverslips were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and blocked with 5% BSA. The samples were incubated with primary antibody against Lamin B1 overnight at 4&#xa0;&#xb0;C, followed by incubation with a fluorescent secondary antibody. The nuclei were counterstained with DAPI, and images were captured using a fluorescence microscope.</p>
</sec>
<sec id="s2-9">
<label>2.9</label>
<title>Apoptosis analysis</title>
<p>Apoptosis was detected using an Annexin V-FITC/PI apoptosis detection kit according to the manufacturer&#x2019;s instructions. After treatment, the cells were collected, resuspended in binding buffer, and stained with Annexin V-FITC and PI for 15&#xa0;min at room temperature in the dark. Apoptotic rates were analysed by flow cytometry within 1&#xa0;h.</p>
</sec>
<sec id="s2-10">
<label>2.10</label>
<title>Statistical analysis</title>
<p>The data are presented as the mean &#xb1; standard deviation (SD) of three independent biological replicates (n &#x3d; 3). The normality of the data distribution was assessed using the Shapiro&#x2013;Wilk test. Differences between groups were analysed by one-way analysis of variance (ANOVA), followed by Tukey&#x2019;s <italic>post hoc</italic> test for multiple comparisons. A value of <italic>P</italic> &#x3c; 0.05 was considered to indicate statistical significance. All the statistical analyses were performed using SPSS 22.0 (IBM Corp., USA). The graphs were generated using GraphPad Prism 9.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<label>3</label>
<title>Results</title>
<sec id="s3-1">
<label>3.1</label>
<title>Cytotoxicity and morphology assessment</title>
<p>To evaluate the biosafety profile of Ectoine, its potential cytotoxicity to HaCaT keratinocytes and EA. hy926 endothelial cells was assessed via a CCK-8 assay after 24&#xa0;h of treatment. As demonstrated in <xref ref-type="fig" rid="F1">Figures 1A,B</xref>, compared with control treatment, treatment with Ectoine at concentrations ranging from 0.25 to 2&#xa0;&#x3bc;mol/L did not significantly decrease cell viability in either cell type (<italic>P</italic> &#x3e; 0.05; n &#x3d; 3), indicating that Ectoine is not cytotoxic within this dose range. Morphological observations further corroborated these findings, revealing that compared with control cells, Ectoine-treated cells retained normal cellular architecture without observable anomalies (<xref ref-type="fig" rid="F1">Figure 1C</xref>). Notably, the Ectoine-treated groups exhibited increased cell density under microscopic evaluation, suggesting a potential pro-proliferative effect that warranted further investigation via an EdU assay.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Evaluation of Ectoine cytotoxicity and its effects on cell morphology. <bold>(A,B)</bold> Viability of HaCaT and EA. hy926 cells treated with Ectoine (0.25&#x2013;2&#xa0;&#x3bc;mol/L) for 24 h, as determined by the CCK-8 assay (n &#x3d; 3 independent biological replicates). <bold>(C)</bold> Morphology of HaCaT and EA. hy926 cells following 24&#xa0;h of Ectoine treatment.</p>
</caption>
<graphic xlink:href="fragi-07-1754569-g001.tif">
<alt-text content-type="machine-generated">Panel A shows a bar graph of HaCaT cell viability at different ectoine concentrations, with no significant differences observed. Panel B displays a similar bar graph for EA.hy926 cells, also without significant changes. Panel C presents microscopy images of HaCaT and EA.hy926 cells at increasing ectoine concentrations, showing no major morphological changes compared to controls.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-2">
<label>3.2</label>
<title>Establishment of an H<sub>2</sub>O<sub>2</sub>-induced senescence model</title>
<p>To establish a model of oxidative stress-induced senescence, HaCaT and EA. hy926 cells were exposed to H<sub>2</sub>O<sub>2</sub> across a concentration gradient of 100&#x2013;400&#xa0;&#x3bc;mol/L for one or 2&#xa0;h. This treatment induced discernible morphological alterations in both cell lines, such as a reduction in the cell number (<xref ref-type="fig" rid="F2">Figure 2A</xref>). As illustrated in <xref ref-type="fig" rid="F2">Figures 2B&#x2013;E</xref>, H<sub>2</sub>O<sub>2</sub> treatment induced a concentration-dependent suppression of viability in both cell lines. On the basis of the conventional senescence criterion corresponding to approximately 70%&#x2013;80% cell viability, the conditions of 200&#xa0;&#x3bc;mol/L H<sub>2</sub>O<sub>2</sub> for 1&#xa0;h (resulting in 87.85% viability) and 100&#xa0;&#x3bc;mol/L H<sub>2</sub>O<sub>2</sub> for 2&#xa0;h (86.10% viability) were selected to induce senescence in HaCaT and EA. hy926 cells, respectively, and these conditions were used in all subsequent experiments.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Effect of H<sub>2</sub>O<sub>2</sub> on the viability of HaCaT and EA. hy926 cells. <bold>(A)</bold> Morphology of HaCaT cells treated with 100&#x2013;400&#xa0;&#x3bc;mol/L H<sub>2</sub>O<sub>2</sub> for 1&#xa0;h and EA. hy926 cells treated with the same concentration range for 2&#xa0;h (&#xd7;20 magnification). <bold>(B&#x2013;E)</bold> Viability of <bold>(B,C)</bold> HaCaT and <bold>(D,E)</bold> EA. hy926 cells after H<sub>2</sub>O<sub>2</sub> exposure for 1&#xa0;h or 2&#xa0;h. The data are presented as the mean &#xb1; SD (n &#x3d; 3 independent biological replicates). &#x23;<italic>P</italic> &#x3c; 0.05, &#x23;&#x23;<italic>P</italic> &#x3c; 0.01 vs. the control group.</p>
</caption>
<graphic xlink:href="fragi-07-1754569-g002.tif">
<alt-text content-type="machine-generated">Panel A presents microscopic images of HaCaT and EA.hy926 cell cultures exposed to increasing concentrations of hydrogen peroxide, displaying decreased cell density at higher concentrations. Panels B to E show bar graphs of cell viability; viability decreases in both cell lines as hydrogen peroxide concentration increases, with detailed comparisons at one hour and two hours post-exposure for each cell type.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-3">
<label>3.3</label>
<title>Ectoine promotes proliferation and reduces senescence-associated &#x3b2;-galactosidase activity</title>
<p>To determine whether Ectoine mitigates H<sub>2</sub>O<sub>2</sub>-induced proliferative arrest, we performed EdU incorporation assays. Cells were pretreated with Ectoine for 24&#xa0;h prior to H<sub>2</sub>O<sub>2</sub> exposure under predetermined optimal senescence-inducing conditions. Quantitative analysis demonstrated that Ectoine pretreatment significantly counteracted the antiproliferative effect of oxidative stress. As shown in <xref ref-type="fig" rid="F3">Figures 3A&#x2013;D</xref>, compared with H<sub>2</sub>O<sub>2</sub>, 0.5 and 1&#xa0;&#x3bc;mol/L Ectoine markedly increased the percentage of EdU-positive HaCaT and EA. hy926 cells (<italic>P</italic> &#x3c; 0.05; n &#x3d; 3), indicating effective restoration of proliferation capacity. This dose-dependent increase in DNA synthesis highlights the role of Ectoine in facilitating cellular replication under oxidative stress.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Ectoine promotes proliferation and reduces senescence in HaCaT and EA. hy926 cells. <bold>(A&#x2013;D)</bold> An EdU assay was used to detect the proliferation of <bold>(A,B)</bold> HaCaT and <bold>(C,D)</bold> EA. hy926 cells after Ectoine treatment. <bold>(E&#x2013;H)</bold> SA-&#x3b2;-gal staining (100&#xd7;) of <bold>(E,F)</bold> HaCaT and <bold>(G,H)</bold> EA. hy926 cells under different treatments. Data are presented as the mean &#xb1; SD (n &#x3d; 3 independent biological replicates). &#x23;<italic>P</italic> &#x3c; 0.05 vs. the control group; &#x2a;<italic>P</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>P</italic> &#x3c; 0.01 vs. the H<sub>2</sub>O<sub>2</sub> group.</p>
</caption>
<graphic xlink:href="fragi-07-1754569-g003.tif">
<alt-text content-type="machine-generated">Scientific figure showing multiple panels of cell staining and quantification graphs. Panels A and C present fluorescence microscopy images for HaCaT and EA.hy926 cells under different treatment conditions, with DAPI and Edu staining for cell proliferation. Panels B and D show bar graphs quantifying Edu positive cell rates, demonstrating statistical differences between conditions. Panels E and G depict microscope images of &#x3B2;-galactosidase-stained cells, while panels F and H present bar graphs quantifying &#x3B2;-gal positive cells, indicating significant differences between groups. Red arrows highlight specific regions of interest in the images.</alt-text>
</graphic>
</fig>
<p>Consistent with the senescent phenotype, compared with the control treatment, H<sub>2</sub>O<sub>2</sub> challenge significantly increased the proportion of SA-&#x3b2;-gal-positive HaCaT (63.89%, <italic>P</italic> &#x3c; 0.05; n &#x3d; 3) and EA. hy926 (72.00%, <italic>P</italic> &#x3c; 0.05; n &#x3d; 3) cells (<xref ref-type="fig" rid="F3">Figures 3E&#x2013;H</xref>). Notably, pretreatment with 0.5 and 1&#xa0;&#x3bc;mol/L Ectoine substantially attenuated this H<sub>2</sub>O<sub>2</sub>-induced increase in SA-&#x3b2;-gal activity (<italic>P</italic> &#x3c; 0.05), demonstrating its strong ability to ameliorate stress-induced premature senescence.</p>
</sec>
<sec id="s3-4">
<label>3.4</label>
<title>Ectoine reduces intracellular ROS levels and preserves Lamin B1 expression</title>
<p>We next investigated the antioxidant potential of Ectoine by measuring intracellular ROS levels following H<sub>2</sub>O<sub>2</sub>-induced oxidative insult. As depicted in <xref ref-type="fig" rid="F4">Figures 4A&#x2013;D</xref>, H<sub>2</sub>O<sub>2</sub> exposure induced substantial ROS accumulation in both cell types. However, pretreatment with 0.5&#xa0;&#x3bc;mol/L Ectoine significantly attenuated this oxidative burst, reducing ROS levels to levels comparable to those in the control groups (<italic>P</italic> &#x3c; 0.05; n &#x3d; 3). These results indicate that Ectoine effectively quenches oxidative stress in both keratinocytes and endothelial cells.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Ectoine attenuates intracellular ROS levels and maintains Lamin B1 expression in HaCaT and EA. hy926 cells. <bold>(A&#x2013;D)</bold> Intracellular ROS levels detected by a DCFH-DA fluorescent probe in <bold>(A,B)</bold> HaCaT and <bold>(C ,D)</bold> EA. hy926 cells. <bold>(E&#x2013;H)</bold> Lamin B1 expression detected by immunofluorescence in <bold>(E,F)</bold> HaCaT and <bold>(G,H)</bold> EA. hy926 cells. The data are presented as the mean &#xb1; SD (n &#x3d; 3 independent biological replicates). &#x23;&#x23;<italic>P</italic> &#x3c; 0.01, &#x23;&#x23;&#x23;<italic>P</italic> &#x3c; 0.001 vs. the control group; &#x2a;<italic>P</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>P</italic> &#x3c; 0.01 vs. the H<sub>2</sub>O<sub>2</sub> group.</p>
</caption>
<graphic xlink:href="fragi-07-1754569-g004.tif">
<alt-text content-type="machine-generated">Fluorescence microscopy images and bar graphs display oxidative stress and fluorescence intensity in HaCaT and EA.hy926 cells under various treatments: control, hydrogen peroxide, and graded concentrations of ectoine with hydrogen peroxide. Panels A and C show green fluorescence for reactive oxygen species in cells; panels B and D present bar graphs of mean DCFH-DA fluorescence quantification. Panels E and F contain immunofluorescence images for lamin B1 (red) and nuclei (DAPI, blue) with merged channels, showing nuclear structure changes under each treatment. Panels G and H display quantification bar graphs corresponding to lamin B1 fluorescence intensity.</alt-text>
</graphic>
</fig>
<p>Given that loss of nuclear membrane integrity is a hallmark of senescence, we assessed Lamin B1 expression via immunofluorescence. Compared with control treatment, H<sub>2</sub>O<sub>2</sub> treatment significantly reduced the Lamin B1-to-DAPI fluorescence ratio (<italic>P</italic> &#x3c; 0.01 for HaCaT; <italic>P</italic> &#x3c; 0.001 for EA. hy926; n &#x3d; 3), indicating disruption of nuclear envelope integrity. Ectoine pretreatment (0.25 and 0.5&#xa0;&#x3bc;mol/L) significantly restored Lamin B1 expression (<italic>P</italic> &#x3c; 0.05 vs. the H<sub>2</sub>O<sub>2</sub> group), suggesting that it plays a role in preserving nuclear architecture and mitigating DNA damage response activation (<xref ref-type="fig" rid="F4">Figures 4E&#x2013;H</xref>).</p>
</sec>
<sec id="s3-5">
<label>3.5</label>
<title>qRT&#x2012;PCR analysis of senescence-related gene expression</title>
<p>qRT&#x2012;PCR analysis revealed that H<sub>2</sub>O<sub>2</sub>-induced oxidative stress significantly upregulated the mRNA expression of pivotal senescence-related genes (<italic>TP53, CDKN1A</italic> and <italic>CDKN2A</italic>) in both cell lines. As illustrated in <xref ref-type="fig" rid="F5">Figure 5</xref>, Ectoine pretreatment effectively suppressed this H<sub>2</sub>O<sub>2</sub>-triggered upregulation. Specifically, 0.5&#xa0;&#x3bc;mol/L Ectoine most potently downregulated mRNA expression in HaCaT cells, while in EA. hy926 cells, 0.5&#x2013;1&#xa0;&#x3bc;mol/L Ectoine most effectively suppressed mRNA expression (all <italic>P</italic> &#x3c; 0.05, n &#x3d; 3), indicating effective inhibition of core senescence pathways under oxidative stress.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Ectoine downregulates senescence-related gene expression in H2O2-induced HaCaT and EA. hy926 cells. The data are presented as the mean &#x00B1; SD (n &#x3D; 3 independent biological replicates). (A) Relative mRNA expression levels of CDKN2A, CDKN1A, and TP53 in HaCaT cells. (i) CDKN2A, (ii) CDKN1A, (iii) TP53. (B) Relative mRNA expression levels of the same genes in EA.hy926 cells. (i) CDKN2A, (ii) CDKN1A, (iii) TP53. <sup>&#x23;</sup>
<italic>P</italic> &#x3c; 0.05, <sup>&#x23;&#x23;</sup>
<italic>P</italic> &#x3c; 0.01, <sup>&#x23;&#x23;&#x23;&#x23;</sup>
<italic>P</italic> &#x3c; 0.0001 vs. the control group; &#x2a;<italic>P</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>P</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>P</italic> &#x3c; 0.001, &#x2a;&#x2a;&#x2a;&#x2a;<italic>P</italic> &#x3c; 0.0001 vs. the H<sub>2</sub>O<sub>2</sub> group.</p>
</caption>
<graphic xlink:href="fragi-07-1754569-g005.tif">
<alt-text content-type="machine-generated">Bar graph panels show relative mRNA expression of CDKN2A, CDKN1A, and TP53 in HaCaT and EA.hy926 cells. Each panel compares control, hydrogen peroxide alone, and increasing concentrations of Ectoin plus hydrogen peroxide, showing decreased gene expression with Ectoin co-treatment. Statistical significance is indicated by asterisks.</alt-text>
</graphic>
</fig>
<p>Given that ROS-driven extracellular matrix (ECM) degradation is a key feature of cellular senescence, we examined the effects of Ectoine on the matrix metalloproteinases MMP2 and MMP9. H<sub>2</sub>O<sub>2</sub> exposure significantly upregulated MMP9 mRNA expression in both cell types and MMP2 expression in EA. hy926 cells (<italic>P</italic> &#x3c; 0.05; n &#x3d; 3). Conversely, in EA. hy926 cells, 0.5&#xa0;&#x3bc;mol/L Ectoine significantly suppressed both MMP2 and MMP9 expression (<italic>P</italic> &#x3c; 0.05; n &#x3d; 3), suggesting that cell type-specific regulation of ECM degradation occurred (<xref ref-type="sec" rid="s12">Supplementary Figure S1</xref>).</p>
</sec>
<sec id="s3-6">
<label>3.6</label>
<title>Ectoine downregulates senescence-related protein expression and inhibits apoptosis</title>
<p>Western blot analysis confirmed the regulatory effects of Ectoine at the protein level. While H<sub>2</sub>O<sub>2</sub> treatment tended to increase p16, p21, and p53 protein expression, Ectoine pretreatment significantly reversed this increase. In both cell lines, 0.5&#xa0;&#x3bc;mol/L Ectoine most effectively suppressed protein expression (<xref ref-type="fig" rid="F6">Figures 6A,B</xref>; <italic>P</italic> &#x3c; 0.05; n &#x3d; 3), demonstrating that Ectoine effectively suppressed senescence-related protein expression under oxidative stress conditions.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Ectoine downregulates senescence-related protein expression and reduces apoptosis in HaCaT and EA. hy926 cells. <bold>(A,B)</bold> Western blot analysis of p16, p21, and p53 protein expression in <bold>(A)</bold> HaCaT and <bold>(B)</bold> EA. hy926 cells. <bold>(C,D)</bold> Apoptosis rate detected by flow cytometry in <bold>(C)</bold> HaCaT and <bold>(D)</bold> EA. hy926 cells. The apoptosis rate was calculated as the sum of early (lower right quadrant) and late (upper right quadrant) apoptotic cells. The data are presented as the mean &#xb1; SD (n &#x3d; 3 independent biological replicates). <sup>&#x23;</sup>
<italic>P</italic> &#x3c; 0.05, <sup>&#x23;&#x23;&#x23;</sup>
<italic>P</italic> &#x3c; 0.001 vs. the control group; &#x2a;<italic>P</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>P</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;&#x2a;<italic>P</italic> &#x3c; 0.0001 vs. the H<sub>2</sub>O<sub>2</sub> group.</p>
</caption>
<graphic xlink:href="fragi-07-1754569-g006.tif">
<alt-text content-type="machine-generated">Immunoblot figures and bar graphs in panels A and B show protein expression levels of LC3 and p62 in HaCaT and EA.hy926 cells after treatments with hydrogen peroxide and various ectoine concentrations; statistical significance is indicated. Flow cytometry dot plots in panels C and D illustrate cell populations for apoptosis analysis under the same treatment conditions, with adjacent bar graphs quantifying apoptotic percentages and statistical differences.</alt-text>
</graphic>
</fig>
<p>Flow cytometric analysis using Annexin V-FITC/PI staining indicated that H<sub>2</sub>O<sub>2</sub> significantly increased apoptosis in HaCaT (6.48% vs. 2.60% in control, <italic>P</italic> &#x3c; 0.001; n &#x3d; 3) and EA. hy926 (8.69% vs. 6.42%; <italic>P</italic> &#x3c; 0.05; n &#x3d; 3) cells. Ectoine pretreatment (0.5&#xa0;&#x3bc;mol/L) significantly attenuated H<sub>2</sub>O<sub>2</sub>-induced apoptosis in a concentration-dependent manner (<italic>P</italic> &#x3c; 0.0001 for HaCaT cells; <italic>P</italic> &#x3c; 0.05 for EA. hy926 cells; n &#x3d; 3), confirming its protective effect against oxidative stress-induced cell death (<xref ref-type="fig" rid="F6">Figures 6C,D</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<label>4</label>
<title>Discussion</title>
<p>In this study, we demonstrated that H<sub>2</sub>O<sub>2</sub> treatment successfully induced cellular senescence in both HaCaT keratinocytes and EA. hy926 endothelial cells, as indicated by increased SA-&#x3b2;-gal activity, elevated intracellular ROS levels, upregulated expression of senescence-related markers (<italic>TP53</italic>, <italic>CDKN1A</italic>, <italic>CDKN2A</italic>, <italic>MMP2</italic>, and <italic>MMP9</italic>) and reduced Lamin B1 expression. Pretreatment with Ectoine, particularly at 0.50&#xa0;&#x3bc;mol/L, significantly attenuated these senescence-associated changes in a concentration-dependent manner.</p>
<p>Cellular senescence can be triggered by oxidative stress, such as exposure to H<sub>2</sub>O<sub>2</sub>, leading to irreversible cell cycle arrest and characteristic phenotypic changes (<xref ref-type="bibr" rid="B18">Pezone et al., 2023</xref>). In the present oxidative stress-induced cellular senescence model, the increase in SA-&#x3b2;-gal activity and the upregulation of senescence markers confirmed the successful establishment of cellular senescence. Ectoine pretreatment markedly reduced SA-&#x3b2;-gal positivity and suppressed the expression of p53, p21, p16 and MMPs while preserving Lamin B1 levels. These results indicate that Ectoine effectively counteracts H<sub>2</sub>O<sub>2</sub>-induced premature senescence in skin-related cells.</p>
<p>Excessive ROS are key drivers of senescence. Studies have shown that natural compounds such as mangiferin can delay H<sub>2</sub>O<sub>2</sub>-induced senescence in skin-related cells, including HaCaT and HSF cells, by modulating ROS and MMP levels (<xref ref-type="bibr" rid="B19">Seo and Jeong, 2015</xref>; <xref ref-type="bibr" rid="B15">Kanoi et al., 2021</xref>). In our model, Ectoine pretreatment significantly decreased intracellular ROS levels and reduced apoptosis in both cell types. Notably, while apoptosis and senescence represent distinct cellular outcomes, the suppression of H<sub>2</sub>O<sub>2</sub>-induced apoptosis by Ectoine may contribute to overall cell survival under oxidative stress conditions. The more pronounced antiapoptotic effect observed in HaCaT cells suggests cell type-specific responses to Ectoine treatment.</p>
<p>The p53/p21 and p16 pathways are central regulators of cellular senescence. <italic>TP53</italic>, activated by DNA damage, induces cell cycle arrest primarily through its downstream target <italic>CDKN1A</italic>, while <italic>CDKN2A</italic> contributes to sustained proliferative arrest (<xref ref-type="bibr" rid="B18">Pezone et al., 2023</xref>). Our data revealed that Ectoine downregulated the mRNA and protein expression of p53, p21, and p16 in H<sub>2</sub>O<sub>2</sub>-treated cells. On the basis of the current evidence, we propose two nonexclusive mechanistic possibilities: Ectoine may act upstream by reducing initial oxidative DNA damage through its antioxidant properties or downstream by suppressing senescence signalling pathways after damage has occurred. The observed reduction in ROS levels supports potential upstream effects, whereas the modulation of p53/p21 and p16 expression is consistent with downstream effects. We propose that our findings represent a &#x201c;mechanism association&#x201d; rather than direct mechanistic proof. Future work must discern whether the protective effect of Ectoine occurs upstream via prevention of DNA damage mediated by ROS or downstream via modulation of the p53/p16 pathway by combining siRNA and &#x3b3;H2AX/53BP1 foci analysis.</p>
<p>Notably, Ectoine has demonstrated significant barrier-protective and anti-inflammatory effects in various physiological models, including intestinal inflammation.&#x200b; Its underlying mechanisms&#x2014;such as inhibiting the activation of classical proinflammatory signalling pathways (e.g., NF-&#x3ba;B and MAPK) and reducing the levels of key proinflammatory mediators (<xref ref-type="bibr" rid="B1">Abdel-Aziz et al., 2013</xref>; <xref ref-type="bibr" rid="B5">Castro-Ochoa et al., 2019</xref>)&#x2014;closely overlap with&#x200b; intracellular signalling cascades triggered by skin photoaging and oxidative stress. The results of the present study confirm that Ectoine effectively mitigates H<sub>2</sub>O<sub>2</sub>-induced senescence in skin-related cells, a benefit likely rooted in its broad regulatory capacity over core inflammatory and stress pathways. Therefore, the barrier-repairing and anti-inflammatory properties observed in intestinal models provide strong theoretical support and novel research insights for the application of Ectoine in skin-related cell antiaging strategies, particularly those targeting inflammatory ageing and compromised skin barrier function. While our study provides evidence for the effects of Ectoine on key senescence markers through MMP2/9 analysis, future investigations should include protein-level validation of MMP activity and broader SASP profiling (e.g., of IL-6, IL-8, and CXCLs) to fully characterize the senescence-associated secretory phenotype. The cell-type-specific variation in Ectoine efficacy between HaCaT and EA. hy926 cells may be attributed to differences in stress response mechanisms or pathway activation, warranting further investigation. Additionally, the relationship between oxidative stress and other cell death mechanisms, such as ferroptosis, merits attention. Recent studies using multilevel experimental validation approaches, including cell models and <italic>in vivo</italic> systems, have demonstrated the role of ferroptosis in ageing and damage models (<xref ref-type="bibr" rid="B22">Yuan et al., 2025</xref>), providing a broader context for understanding the potential protective mechanisms of Ectoine.</p>
<p>Ectoine is known for its ability to stabilize biomacromolecules and protect cells under extreme conditions (<xref ref-type="bibr" rid="B13">Hseu et al., 2020</xref>; <xref ref-type="bibr" rid="B7">Chen et al., 2020</xref>). Although our study focused on senescence-related gene expression, the underlying mechanisms may involve &#x201c;preferential hydration&#x201d;, and interactions with signalling pathways such as ERK1/2, JNK, and P38 MAPK pathways (<xref ref-type="bibr" rid="B4">Cai et al., 2021</xref>) warrant further investigation. Given its anti-inflammatory and membrane-stabilizing properties, the utility of Ectoine may extend to neuroprotection, particularly in Alzheimer&#x2019;s disease, where oxidative stress, protein misfolding, and inflammation are involved. Future work should employ advanced models, such as A&#x3b2;-treated neuronal cultures or transgenic Alzheimer&#x2019;s models, to validate its efficacy in neural systems. In conclusion, Ectoine effectively counteracts H<sub>2</sub>O<sub>2</sub>-induced senescence in skin-related cells, supporting its potential in antiaging skincare. Moreover, its pleiotropic mechanisms, including biomacromolecule stabilization, antiaggregation, and pathway modulation, suggest promising translational value for addressing neurological ageing and related disorders, meriting expanded interdisciplinary research.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>.</p>
</sec>
<sec sec-type="ethics-statement" id="s6">
<title>Ethics statement</title>
<p>Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used. Ethical approval was not required for the studies on animals in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>ML: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Project administration, Software, Supervision, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review and editing. JZ: Data curation, Formal Analysis, Methodology, Software, Supervision, Visualization, Writing &#x2013; review and editing, Funding acquisition, Resources. WY: Conceptualization, Data curation, Investigation, Methodology, Resources, Supervision, Validation, Writing &#x2013; review and editing. ZM: Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Writing &#x2013; original draft. YP: Data curation, Resources, Supervision, Writing &#x2013; review and editing. YY: Data curation, Resources, Supervision, Visualization, Writing &#x2013; review and editing. JS: Project administration, Resources, Supervision, Writing &#x2013; review and editing. XG: Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing &#x2013; review and editing. YL: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s10">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was used in the creation of this manuscript. The authors declare that AI was used for language editing in this study but not for data generation or any other purpose.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fragi.2026.1754569/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fragi.2026.1754569/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Supplementaryfile1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdel-Aziz</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wadie</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Abdallah</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Lentzen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Khayyal</surname>
<given-names>M. T.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Novel effects of ectoine, a bacteria-derived natural tetrahydropyrimidine, in experimental colitis</article-title>. <source>Phytomedicine</source> <volume>20</volume> (<issue>7</issue>), <fpage>585</fpage>&#x2013;<lpage>591</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2013.01.009</pub-id>
<pub-id pub-id-type="pmid">23453305</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bownik</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>St&#x119;pniewska</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Protective effects of bacterial osmoprotectant ectoine on bovine erythrocytes subjected to staphylococcal alpha-haemolysin</article-title>. <source>Toxicon</source> <volume>99</volume>, <fpage>130</fpage>&#x2013;<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2015.03.022</pub-id>
<pub-id pub-id-type="pmid">25841345</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bownik</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>St&#x119;pniewska</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Ectoine as a promising protective agent in humans and animals</article-title>. <source>Arh. Za Hig. Rada I Toksikol.</source> <volume>67</volume> (<issue>4</issue>), <fpage>260</fpage>&#x2013;<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1515/aiht-2016-67-2837</pub-id>
<pub-id pub-id-type="pmid">28033102</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Men</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Protective mechanism of humanin against oxidative stress in aging-related cardiovascular diseases</article-title>. <source>Front. Endocrinol.</source> <volume>12</volume>, <fpage>683151</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2021.683151</pub-id>
<pub-id pub-id-type="pmid">34177809</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castro-Ochoa</surname>
<given-names>K. F.</given-names>
</name>
<name>
<surname>Vargas-Robles</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ch&#xe1;nez-Paredes</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Felipe-L&#xf3;pez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cabrera-Silva</surname>
<given-names>R. I.</given-names>
</name>
<name>
<surname>Shibayama</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Homoectoine protects against colitis by preventing a claudin switch in epithelial tight junctions</article-title>. <source>Dig. Dis. Sci.</source> <volume>64</volume> (<issue>2</issue>), <fpage>409</fpage>&#x2013;<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1007/s10620-018-5309-8</pub-id>
<pub-id pub-id-type="pmid">30269272</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chavez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Si</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>A. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Carbon nanodots inhibit tumor necrosis Factor-&#x3b1;-Induced endothelial inflammation through scavenging hydrogen peroxide and upregulating antioxidant gene expression in EA.hy926 endothelial cells</article-title>. <source>Antioxidants Basel, Switz.</source> <volume>13</volume> (<issue>2</issue>), <fpage>224</fpage>. <pub-id pub-id-type="doi">10.3390/antiox13020224</pub-id>
<pub-id pub-id-type="pmid">38397822</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>P.-W.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Z. Y.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Chi-Wei Lan</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Exploring the additive bio-agent impacts upon ectoine production by Halomonas salina DSM5928T using corn steep liquor and soybean hydrolysate as nutrient supplement</article-title>. <source>J. Biosci. Bioeng.</source> <volume>130</volume> (<issue>2</issue>), <fpage>195</fpage>&#x2013;<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiosc.2020.03.011</pub-id>
<pub-id pub-id-type="pmid">32370929</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Csekes</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ra&#x10d;kov&#xe1;</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Skin aging, cellular senescence and natural polyphenols</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume> (<issue>23</issue>), <fpage>12641</fpage>. <pub-id pub-id-type="doi">10.3390/ijms222312641</pub-id>
<pub-id pub-id-type="pmid">34884444</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Czech</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Poehl</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hub</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>St&#xf6;veken</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bremer</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Tinkering with osmotically controlled transcription allows enhanced production and excretion of ectoine and hydroxyectoine from a microbial cell factory</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>84</volume> (<issue>2</issue>). <pub-id pub-id-type="doi">10.1128/AEM.01772-17</pub-id>
<pub-id pub-id-type="pmid">29101191</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galinski</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Pfeiffer</surname>
<given-names>H. P.</given-names>
</name>
<name>
<surname>Tr&#xfc;per</surname>
<given-names>H. G.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>1,4,5,6-Tetrahydro-2-methyl-4-pyrimidinecarboxylic acid. A novel cyclic amino acid from halophilic phototrophic bacteria of the genus ectothiorhodospira</article-title>. <source>Eur. J. Biochem.</source> <volume>149</volume> (<issue>1</issue>), <fpage>135</fpage>&#x2013;<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1985.tb08903.x</pub-id>
<pub-id pub-id-type="pmid">3838936</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harishchandra</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Wulff</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lentzen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Neuhaus</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Galla</surname>
<given-names>H. J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>The effect of compatible solute ectoines on the structural organization of lipid monolayer and bilayer membranes</article-title>. <source>Biophys. Chem.</source> <volume>150</volume> (<issue>1-3</issue>), <fpage>37</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpc.2010.02.007</pub-id>
<pub-id pub-id-type="pmid">20206435</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Held</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sadowski</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Compatible solutes: thermodynamic properties relevant for effective protection against osmotic stress</article-title>. <source>Fluid Phase Equilibria</source> <volume>407</volume>, <fpage>224</fpage>&#x2013;<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1016/j.fluid.2015.07.004</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hseu</surname>
<given-names>Y.-C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X. Z.</given-names>
</name>
<name>
<surname>Vudhya Gowrisankar</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yen</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H. L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The skin-whitening effects of ectoine <italic>via</italic> the suppression of &#x3b1;-MSH-Stimulated melanogenesis and the activation of antioxidant Nrf2 pathways in UVA-Irradiated keratinocytes</article-title>. <source>Antioxidants Basel, Switz.</source> <volume>9</volume> (<issue>1</issue>). <pub-id pub-id-type="doi">10.3390/antiox9010063</pub-id>
<pub-id pub-id-type="pmid">31936771</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jackson</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Bartek</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>The DNA-damage response in human biology and disease</article-title>. <source>Nature</source> <volume>461</volume> (<issue>7267</issue>), <fpage>1071</fpage>&#x2013;<lpage>1078</lpage>. <pub-id pub-id-type="doi">10.1038/nature08467</pub-id>
<pub-id pub-id-type="pmid">19847258</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanoi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Loachan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>B. S. S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Mangiferin, a naturally occurring polyphenol, mitigates oxidative stress induced premature senescence in human dermal fibroblast cells</article-title>. <source>Mol. Biol. Rep.</source> <volume>48</volume> (<issue>1</issue>), <fpage>457</fpage>&#x2013;<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1007/s11033-020-06074-2</pub-id>
<pub-id pub-id-type="pmid">33393007</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krutmann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schikowski</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Morita</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Berneburg</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Environmentally-Induced (Extrinsic) skin aging: exposomal factors and underlying mechanisms</article-title>. <source>J. Investigative Dermatology</source> <volume>141</volume> (<issue>4S</issue>), <fpage>1096</fpage>&#x2013;<lpage>1103</lpage>. <pub-id pub-id-type="doi">10.1016/j.jid.2020.12.011</pub-id>
<pub-id pub-id-type="pmid">33541724</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nistic&#xf2;</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ehrlich</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gliozzi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Maiuolo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Del Duca</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Muscoli</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>TElomere and telomerase modulation by bergamot polyphenolic fraction in experimental photoageing in human keratinocytes</article-title>. <source>J. Biol. Regul. Homeost. Agents</source> <volume>29</volume> (<issue>3</issue>), <fpage>723</fpage>&#x2013;<lpage>728</lpage>.<pub-id pub-id-type="pmid">26403416</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pezone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Olivieri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Napoli</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Procopio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Avvedimento</surname>
<given-names>E. V.</given-names>
</name>
<name>
<surname>Gabrielli</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Inflammation and DNA damage: cause, effect or both</article-title>. <source>Nat. Rev. Rheumatol.</source> <volume>19</volume> (<issue>4</issue>), <fpage>200</fpage>&#x2013;<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1038/s41584-022-00905-1</pub-id>
<pub-id pub-id-type="pmid">36750681</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seo</surname>
<given-names>S.-H.</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>G.-S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Fisetin inhibits TNF-&#x3b1;-induced inflammatory action and hydrogen peroxide-induced oxidative damage in human keratinocyte HaCaT cells through PI3K/AKT/Nrf-2-mediated heme oxygenase-1 expression</article-title>. <source>Int. Immunopharmacol.</source> <volume>29</volume> (<issue>2</issue>), <fpage>246</fpage>&#x2013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2015.11.014</pub-id>
<pub-id pub-id-type="pmid">26590114</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kum</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Protective effects of a new phloretin derivative against UVB-induced damage in skin cell model and human volunteers</article-title>. <source>Int. J. Mol. Sci.</source> <volume>15</volume> (<issue>10</issue>), <fpage>18919</fpage>&#x2013;<lpage>18940</lpage>. <pub-id pub-id-type="doi">10.3390/ijms151018919</pub-id>
<pub-id pub-id-type="pmid">25334063</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tubbs</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nussenzweig</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Endogenous DNA damage as a source of genomic instability in cancer</article-title>. <source>Cell</source> <volume>168</volume> (<issue>4</issue>), <fpage>644</fpage>&#x2013;<lpage>656</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.01.002</pub-id>
<pub-id pub-id-type="pmid">28187286</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Experimental validation and identification of ferroptosis-associated biomarkers for diagnostic and therapeutic targeting in hearing loss</article-title>. <source>Front. Aging Neurosci.</source> <volume>17</volume>, <fpage>1526519</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2025.1526519</pub-id>
<pub-id pub-id-type="pmid">40353062</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>P.-C.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zong</surname>
<given-names>S. Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>D. Z.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Variation of ferroptosis-related markers in HaCaT cell photoaging models induced by UVB</article-title>. <source>Clin. Cosmet. Investigational Dermatology</source> <volume>16</volume>, <fpage>3147</fpage>&#x2013;<lpage>3155</lpage>. <pub-id pub-id-type="doi">10.2147/CCID.S433071</pub-id>
<pub-id pub-id-type="pmid">37937317</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1420653/overview">Gregory David</ext-link>, NYU Langone Health, United States</p>
</fn>
<fn fn-type="custom" custom-type="reviewed-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2049173/overview">Akimitsu Konishi</ext-link>, Dokkyo Medical University, Japan</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1548911/overview">Chen Feng</ext-link>, Qilu Hospital, Shandong University, China</p>
</fn>
</fn-group>
<fn-group>
<fn fn-type="abbr" id="abbrev1">
<label>Abbreviations:</label>
<p>ROS, Reactive Oxygen Species; SA-&#x3b2;-gal, Senescence-associated &#x3b2;-galactosidase; ECM, Extracellular Matrix; MMPs, Matrix Metalloproteinases; EdU, 5-Ethynyl-2&#x2032;-deoxyuridine; CCK-8, Cell Counting Kit-8; DAPI, 4&#x2032;,6-Diamidino-2-phenylindole; RT&#x2012;qPCR, Reverse Transcription Quantitative Polymerase Chain Reaction; DMEM, Dulbecco&#x2019;s Modified Eagle Medium; HUVEC, Human Umbilical Vein Endothelial Cells.</p>
</fn>
</fn-group>
</back>
</article>